Amy Ripka: Mitochondrial Dysfunction and New Ideas in Drug Discovery
Listen now
Description
Amy Ripka is the founder and CEO of Lucy Therapeutics. This back of the napkin conversation focuses on the importance of having the freedom to explore and generate new ideas.  The approach that Amy advocates in this podcast has led her to pivotal new discoveries, including potential new therapeutics for Parkinson's disease and Rett syndrome. Lucy therapeutics: https://www.lucytherapeutics.com/ Paper - Playing Mozart to Chemical Reactions: https://jabde.com/2022/04/08/echocatalysis-playing-mozart-to-chemical-reactions/  [https://jabde.com/2022/04/08/echocatalysis-playing-mozart-to-chemical-reactions/]
More Episodes
Heart disease claims more lives than any other illness, marking a dire need for viable heart transplants. Yet, the sheer demand for donor hearts outstrips the supply, burdened further by complications such as organ rejection and the continuous need for immunosuppressive drugs post-transplant. Dr....
Published 04/29/24
Kevan M. Shokat is Professor in the Department of Cellular and Molecular Pharmacology at the University of California San Francisco (UCSF), Professor in the Department of Chemistry at the University of California Berkeley (UCB), and an Investigator with the Howard Hughes Medical Institute (HHMI)....
Published 04/03/24